Cambridge Healthtech Institute’s 5th Annual
Cell Culture and Bioproduction
Best Practices, Efficiencies and Emerging Technologies
22-23 March 2022
Cambridge Healthtech Institute’s 5th Annual Cell Culture and Bioproduction conference examines technologies and strategies that lead to greater productivity for cultivating cells and scaling these systems for clinical and commercial production.
The meeting includes coverage of exciting new bioreactor technologies, the increasing role of digital technologies, new process control systems and the application of these tools in the rapid development of therapeutics and vaccines during the pandemic.
This popular best practices forum brings together researchers, engineers and solution providers for essential dialog to help advance this dynamic field.
Coverage will include, but is not limited to:All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Emerging Bioreactor Technologies and Applications
• New/novel bioreactor technologies
• Intelligent robotics for process optimization
• Tissue engineering in bioreactors
Case Studies: Implementing Digital Solutions for Cell Culture and Process Development
• Data collection, curation and storage challenges
• AI/ML tools for determining process parameters
• AI/ML tools for refining and selecting culture conditions
Problems and Solutions
post translational modifications
• In vitro transcription translation for antibodies
• Management and monitoring of standardized cell cultures
• Computational fluid dynamics
• Coupling parallelization of bioprocess development with model-based design
• Applying microfluidic tools at large scale for single cell analysis in process modeling
PAT, Process Monitoring and Control
• Case studies of developing and implementing solution integrations
• Emerging technologies for online and inline monitoring
• Emerging technologies for at-line monitoring and analysis
Upstream Processing for Vaccines and Emerging Biotherapeutics
• Measurement and control of glycosylation in spike proteins
• Scale-up and transfer of new mRNA technologies
• Upstream processing impacts for distributed and flexible vaccine production facilities
If you would like
to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is Friday 10 September.